Biomedical Engineering Reference
In-Depth Information
5. Frommer, M., McDonald, L. E., Millar, D. S., et al. (1992) A genomic sequencing
protocol that yields a positive display of 5-methylcytosine residues in individual
DNA strands.
Proc. Natl. Acad. Sci. USA
89,
1827-1831.
6. Xiong, Z. and Laird, P. W. (1997) COBRA: a sensitive and quantitative DNA
methylation assay.
Nucleic Acids Res.
25,
2532-2534.
7. Gonzalgo, M. L. and Jones, P. A. (1997) Rapid quantitation of methylation differ-
ences at specific sites using methylation-sensitive single nucleotide primer exten-
sion (Ms-SNuPE).
Nucleic Acids Res.
25,
2529-2531.
8. Lo, Y. M. D., Wong, I. H. N., Zhang, J., Tein, M. S., Ng, M. H., and Hjelm, N. M.
(1999) Quantitative analysis of aberrant p16 methylation using real-time
quantitative methylation-specific polymerase chain reaction.
Cancer Res.
59,
3899-3903.
9. Wong, I. H. N., Lo, Y. M. D., Zhang, J., et al. (1999) Detection of aberrant
p16 methylation in the plasma and serum of liver cancer patients.
Cancer Res.
59,
71-73.
10. Wong, I. H. N., Ng, M. H., Huang, D. P., and Lee, J. C. (2000) Aberrant p15
promoter methylation in adult and childhood acute leukemias of nearly all
morphologic subtypes: potential prognostic implications.
Blood
95,
1942-1949.
11. Wong, I. H. N., Lo, Y. M. D., Yeo, W., Lau, W. Y., and Johnson, P. J. (2000)
Frequent p15 promoter methylation in tumor and peripheral blood from hepato-
cellular carcinoma patients.
Clin. Cancer Res.
6,
3516-3521.
12. Yamada, Y., Watanabe, H., Miura, F., et al. (2004) A comprehensive analysis of
allelic methylation status of CpG islands on human chromosome 21q.
Genome
Res.
14,
247-266.
13. Wong, I. H. N., Chan, J., Wong, J., and Tam, P. K. (2004) Ubiquitous aberrant
RASSF1A promoter methylation in childhood neoplasia.
Clin. Cancer Res.
10,
994-1002.
14. Esteller, M. (2005) Dormant hypermethylated tumour suppressor genes: ques-
tions and answers.
J. Pathol.
205,
172-180.
15. Baylin, S. and Bestor, T. H. (2002) Altered methylation patterns in cancer cell
genomes: cause or consequence?
Cancer Cell
1,
299-305.
16. Laird, P. W. (2005) Cancer epigenetics.
Hum. Mol. Genet.
14(Spec No 1),
R65-R76.
17. Esteller, M., Sanchez-Cespedes, M., Rosell, R., Sidransky, D., Baylin, S. B., and
Herman, J. G. (1999) Detection of aberrant promoter hypermethylation of tumor
suppressor genes in serum DNA from non-small cell lung cancer patients.
Cancer
Res.
59,
67-70.
18. Grady, W. M., Rajput, A., Lutterbaugh, J. D., and Markowitz, S. D. (2001) Detec-
tion of aberrantly methylated hMLH1 promoter DNA in the serum of patients
with microsatellite unstable colon cancer.
Cancer Res.
61,
900-902.
19. Hayatsu, H., Wataya, Y., and Kazushige, K. (1970) The addition of sodium
bisulfite to uracil and to cytosine.
J. Am. Chem. Soc.
92,
724-726.
20. Clark, S. J., Harrison, J., Paul, C. L., and Frommer, M. (1994) High sensitivity
mapping of methylated cytosines.
Nucleic Acids Res.
22,
2990-2997.
